Senior insider sale
UNITED THERAPEUTICS CORP — senior position signals high conviction
$148.2K
605.00 shares
What this filing means
MESA NILDA plans to sell 605.00 shares of UNITED THERAPEUTICS CORP valued at approximately $148.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/19/2023ACC: 0001950047-23-006329
605.00
Shares to sell
$148.2K
Approx. market value
605.00
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock
Not Applicable
7/8/2022
605.00Total acquired605.00
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/8/2022 | Restricted Stock Not Applicable | 605.00 | — |
| Total | 605.00 | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
605.00
Market value
$148.2K
12/19/2023
Total
Units
605.00
Value
$148.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
12/19/2023 | 605.00 | $148.2K | NASDAQ | Planned |
| Total | 605.00 | $148.2K | ||